- Who We Serve
- Client Sign In
Research from Goldman Sachs and Good Judgment Inc. highlights how pivotal the positive news regarding the experimental vaccine candidate being developed by Pfizer Inc. and Germany-based BioNTech SE was for some market sectors.
As it illustrates, the energy and materials sectors, which have significantly lagged behind the broader market, both saw the most excess positive returns to the news on Monday.
Schedule a consultation to learn how our FutureFirst monitoring tool, custom Superforecasts, and training services can help your organization make better decisions.